La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)  Facettes :

List of bibliographic references indexed by Parkinson Disease (drug therapy)

Number of relevant bibliographic references: 464.
[40-60] [0 - 20][0 - 50][60-80]
Ident.Authors (with country if any)Title
000718 (2015) Alfonso Fasano [Canada] ; Naomi P. Visanji [Canada] ; Louis W C. Liu [Canada] ; Antony E. Lang [Canada] ; Ronald F. Pfeiffer [États-Unis]Gastrointestinal dysfunction in Parkinson's disease.
000731 (2015) Zaijun Zhang [République populaire de Chine] ; Guohui Li [République populaire de Chine] ; Samuel S W. Szeto [République populaire de Chine] ; Cheong Meng Chong [République populaire de Chine] ; Quan Quan [République populaire de Chine] ; Chen Huang [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Baojian Guo [République populaire de Chine] ; Yuqiang Wang [République populaire de Chine] ; Yifan Han [République populaire de Chine] ; K W Michael Siu [Canada] ; Simon Ming Yuen Lee [République populaire de Chine] ; Ivan K. Chu [République populaire de Chine]Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease.
000735 (2015) Justine Renaud [Canada] ; Seyed Fazel Nabavi [Iran] ; Maria Daglia [Italie] ; Seyed Mohammad Nabavi [Iran] ; Maria-Grazia Martinoli [Canada]Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease?
000747 (2015) Karl Kieburtz [États-Unis] ; Barbara C. Tilley ; Jordan J. Elm ; Debra Babcock [États-Unis] ; Robert Hauser [États-Unis] ; G Webster Ross [États-Unis] ; Alicia H. Augustine [États-Unis] ; Erika U. Augustine [États-Unis] ; Michael J. Aminoff [États-Unis] ; Ivan G. Bodis-Wollner ; James Boyd ; Franca Cambi ; Kelvin Chou ; Chadwick W. Christine [États-Unis] ; Michelle Cines [États-Unis] ; Nabila Dahodwala [États-Unis] ; Lorelei Derwent [Canada] ; Richard B. Dewey ; Katherine Hawthorne [États-Unis] ; David J. Houghton [États-Unis] ; Cornelia Kamp [États-Unis] ; Maureen Leehey ; Mark F. Lew [États-Unis] ; Grace S Lin Liang [États-Unis] ; Sheng T. Luo ; Zoltan Mari [États-Unis] ; John C. Morgan ; Sotirios Parashos [États-Unis] ; Adriana Pérez ; Helen Petrovitch [États-Unis] ; Suja Rajan ; Sue Reichwein [États-Unis] ; Jessie Tatsuno Roth [États-Unis] ; Jay S. Schneider [États-Unis] ; Kathleen M. Shannon [États-Unis] ; David K. Simon [États-Unis] ; Tanya Simuni [États-Unis] ; Carlos Singer [États-Unis] ; Lewis Sudarsky [États-Unis] ; Caroline M. Tanner [États-Unis] ; Chizoba C. Umeh [États-Unis] ; Karen Williams [États-Unis] ; Anne-Marie Wills [États-Unis]Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
000748 (2015) Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie]Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.
000750 (2015) Joe Kakish ; Dongsoo Lee ; Jeremy S. LeeDrugs That Bind to α-Synuclein: Neuroprotective or Neurotoxic?
000752 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie]Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
000769 (2015) Mateusz Zurowski [Canada] ; Jonathan Darcy O'BrienDevelopments in impulse control behaviours of Parkinson's disease.
000771 (2015) Line Beaudet [Canada] ; Francine Ducharme [Canada] ; Nathalie L'Écuyer [Canada] ; Sylvain Chouinard [Canada] ; Nicolas Jodoin [Canada] ; Michel Panisset [Canada]Development and evaluation of a dyadic intervention for elderly couples living with moderate-stage Parkinson disease.
000786 (2015) Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
000788 (2015) Alison C. Simioni ; Alain Dagher ; Lesley K. FellowsCompensatory striatal–cerebellar connectivity in mild–moderate Parkinson's disease
000794 (2015) Camila Catherine Aquino [Canada] ; Susan H. FoxClinical spectrum of levodopa-induced complications.
000812 (2015) Isabelle Beaulieu-Boire [Canada] ; Anthony E. LangBehavioral effects of levodopa.
000828 (2015) Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.
000867 (2014) Fariborz Rahimi [Iran] ; Carina Bee [Canada] ; Christian Duval [Canada] ; Patrick Boissy [Canada] ; Roderick Edwards [Canada] ; Mandar Jog [Canada]Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease.
000871 (2014) Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada]Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias.
000882 (2014) Robert A. Hauser [États-Unis] ; C Warren Olanow [États-Unis] ; Karl D. Kieburtz [États-Unis] ; Emmanuelle Pourcher [Canada] ; Any Docu-Axelerad [Roumanie] ; Mark Lew [États-Unis] ; Olexandr Kozyolkin [Ukraine] ; Ann Neale [États-Unis] ; Chris Resburg [États-Unis] ; Uwe Meya [États-Unis] ; Christopher Kenney [États-Unis] ; Stephen Bandak [États-Unis]Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.
000888 (2014) Omid Tavassoly [Canada] ; Joe Kakish [Canada] ; Sergiy Nokhrin [Canada] ; Oleg Dmitriev [Canada] ; Jeremy S. Lee [Canada]The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease.
000904 (2014) Magda Osman [Royaume-Uni] ; Agata Ryterska [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; Lingling Tu [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
000905 (2014) Julie Nantel [Canada] ; Helen Bronte-Stewart [États-Unis]The effect of medication and the role of postural instability in different components of freezing of gait (FOG).
000932 (2014) Michel Panisset [Canada] ; Jack J. Chen ; Sean H. Rhyee ; Jill Conner ; Julie MathenaSerotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022